These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autoantibodies in scleroderma. Pollard KM; Reimer G; Tan EM Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161 [TBL] [Abstract][Full Text] [Related]
6. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Bernstein RM; Steigerwald JC; Tan EM Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633 [TBL] [Abstract][Full Text] [Related]
8. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [TBL] [Abstract][Full Text] [Related]
9. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. Harvey G; Black C; Maddison P; McHugh N J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652 [TBL] [Abstract][Full Text] [Related]
11. [Anti-Scl-70 antibodies in systemic scleroderma]. Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650 [TBL] [Abstract][Full Text] [Related]
12. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047 [TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma. Kleinsmith DM; Heinzerling RH; Burnham TK Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766 [TBL] [Abstract][Full Text] [Related]
14. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Reimer G; Steen VD; Penning CA; Medsger TA; Tan EM Arthritis Rheum; 1988 Apr; 31(4):525-32. PubMed ID: 2451921 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil. Skare TL; Fonseca AE; Luciano AC; Azevedo PM An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893 [TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon. Cruz M; Mejia G; Lavalle C; Cortes JJ; Reyes PA Clin Rheumatol; 1988 Mar; 7(1):80-6. PubMed ID: 3261675 [TBL] [Abstract][Full Text] [Related]
17. Anti-U1RNP antibodies in patients with localized scieroderma. Yamane K; Ihn H; Kubo M; Kuwana M; Asano Y; Yazawa N; Tamaki K Arch Dermatol Res; 2001 Sep; 293(9):455-9. PubMed ID: 11758788 [TBL] [Abstract][Full Text] [Related]